Once-Weekly TransCon™ CNP Achieved Primary Efficacy Objective in ACcomplisH China Phase 2 Trial
![VISEN Pharmaceuticals - TransCon CNP Trial Results Announcement](https://wellnessnews24.com/wp-content/uploads/2023/11/pexels-polina-tankilevitch-3873146-720x530.jpg)
3 min read
VISEN Pharmaceuticals (VISEN), an innovative biopharmaceutical company focused on endocrine diseases, is pleased to announce the topline...